Evolus

Evolus

EOLS· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock -39.8% in FY2025

David Moatazedi is the CEO of Evolus and was paid $6.4M in FY2025 (Dec), down 8%.

Pay$100 in the stock at the end of FY21 → $102
CEO pay is from each Evolus proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives5

See all
  1. 1David MoatazediFY2025
  2. 2Tatjana MitchellFY2025
  3. 3Sandra BeaverFY2025
  4. 4Rui Avelar, M.D.FY2025
  5. 5Tomoko Yamagishi-DresslerFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Evolus paid its 5 named executives $14.6M in total in FY2025 (Dec). CEO David Moatazedi was paid $6.4M of that.

Name
David MoatazediPresident and Chief Executive Officer
Tatjana MitchellChief Financial Officer
Sandra BeaverFormer Chief Financial Officer
Rui Avelar, M.D.Chief Medical Officer and Head of Research and Development
Tomoko Yamagishi-DresslerFormer Chief Marketing Officer

of each named executive, from the Summary Compensation Table of each proxy.

Peers18

See all

The FY2025 (Dec) proxy of Evolus names 18 peer companies for pay. Among Evolus and these peers, CEO pay was 7th highest of 8 and total shareholder return was 6th highest of 8.

7th highest of 8in Evolus and its pay peers, FY2025 (Dec) by CEO pay:

$2.9M$12.0M

6th highest of 8in Evolus and its pay peers, FY2025 (Dec) by total shareholder return:

$30$364

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Board1

See all
  • Brady StewartDirector · 3 yr on the boardIndependentAudit, Nominating and Corporate Governance—Paid as an executive

The board of the latest proxy (FY2025).

Activity

  1. PayDEF 14A
  2. PayDEF 14A
  3. PayDEF 14A
  4. PayDEF 14A
  5. PayDEF 14A
  6. PayDEF 14A
  7. PayDEF 14A
  8. PayDEF 14A

Filings6

See all
Proxy statementDEF 14AApr 29, 2026FY2025
Annual report10-KMar 3, 2026FY2025
Proxy statementDEF 14AApr 25, 2025FY2024
Annual report10-KMar 4, 2025FY2024
Proxy statementDEF 14AApr 26, 2024FY2023
Annual report10-KMar 7, 2024FY2023